Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial

Stéphanie A. Blankenstein, Maartje W. Rohaan, Willem Martin C. Klop, Bernies van der Hiel, Bart A. van de Wiel, Max J. Lahaye, Sandra Adriaansz, Karolina Sikorska, Harm van Tinteren, Aysegül Sari, Lindsay G. Grijpink-Ongering, Winan J. van Houdt, Michel W.J.M. Wouters, Christian U. Blank, Sofie Wilgenhof, Johannes V. van Thienen, Alexander C.J. van Akkooi, John B.A.G. Haanen

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry